Gland Pharma (NSE:GLAND, BOM:543245) has an average rating of hold and price targets ranging from 1,162 Indian rupees to 3,120 rupees, according to analysts polled by Capital IQ.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)